SCHEMBL9563418

SCHEMBL9563418

CC(C)(C)ON(C=O)CCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640905 0.88 HIF1A (0.35)
SCHEMBL447191 0.78
SCHEMBL7152186 0.78
SCHEMBL5156789 0.78
SCHEMBL21293786 0.78
SCHEMBL567668 0.78 TDP1 (0.31)
SCHEMBL4502028 0.78 TDP1 (0.33)
SCHEMBL6007388 0.78 ADH1B (0.37)
SCHEMBL937940 0.77 TDP1 (0.31)
SCHEMBL6209232 0.77 ADH1C (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101941964-A Has the Chemokine Receptors bonded heterogeneous ring compound that promotes effect ANORMED INC 2011-01-12 CN disclosed
CN-1777423-A Chemokine receptor binding heterocyclic compounds with enhanced efficacy ANORMED INC (CA) 2006-05-24 CN disclosed
EP-0556585-A2 Condensed camptothecin derivatives their production and use as antitumor agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-08-25 EP disclosed
CN-1060291-A The novel method of preparation 6-acyl group-7-deacetylforskolin derivatives HOECHST JAPAN (JP) 1992-04-15 CN disclosed